|By PR Newswire||
|April 28, 2014 07:15 AM EDT||
BOTHELL, Wash. and VANCOUVER, British Columbia, April 28, 2014 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that the Company's first quarter 2014 financial results will be released on Wednesday, April 30, 2014, and that the Company will host a conference call and live webcast at 4:30 p.m. ET that afternoon. Management will provide an overview of the company's financial results, development programs and a general business update.
To access the webcast, log on to the Investor Relations page of the OncoGenex website at www.oncogenex.com. Alternatively, you may access the live conference call by dialing (877) 606-1416 (U.S. & Canada) or (707) 287-9313 (International). A webcast replay will be available approximately two hours after the call and will be archived on www.oncogenex.com for 90 days.
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development. More information is available at www.OncoGenex.com and at the company's Twitter account: https://twitter.com/OncoGenex_IR.
SOURCE OncoGenex Pharmaceuticals, Inc.
Aug. 30, 2016 05:45 AM EDT Reads: 2,448
Aug. 30, 2016 03:45 AM EDT Reads: 472
Aug. 30, 2016 02:30 AM EDT Reads: 1,856
Aug. 30, 2016 02:00 AM EDT Reads: 2,240
Aug. 30, 2016 01:30 AM EDT Reads: 3,051
Aug. 30, 2016 01:15 AM EDT Reads: 2,347
Aug. 30, 2016 01:00 AM EDT Reads: 1,939
Aug. 30, 2016 12:00 AM EDT Reads: 1,668
Aug. 29, 2016 10:00 PM EDT Reads: 2,491
Aug. 29, 2016 08:30 PM EDT Reads: 2,450
Aug. 29, 2016 08:15 PM EDT Reads: 1,877
Aug. 29, 2016 08:00 PM EDT Reads: 926
Aug. 29, 2016 07:00 PM EDT Reads: 1,985
Aug. 29, 2016 06:45 PM EDT Reads: 855
Aug. 29, 2016 06:15 PM EDT Reads: 803